§ Tim LoughtonTo ask the Secretary of State for Health what recent discussions he has had with management of Glaxo Smithkline about production of component vaccines of MMR. [71095]
§ Ms Blears[holding answer 17 July 2002]: Glaxo Smithkline informed officials that a decision had been taken by the company at a global level to stop production of single rubella vaccine. This information was unsolicited.